USA flag logo/image

An Official Website of the United States Government

STTR Phase I: Scaleable, Inexpensive Production of siRNA in E. coli

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
88445
Program Year/Program:
2008 / STTR
Agency Tracking Number:
0738336
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIOTEX, INC.
8058 EL RIO ST HOUSTON, TX -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2008
Title: STTR Phase I: Scaleable, Inexpensive Production of siRNA in E. coli
Agency: NSF
Contract: 0738336
Award Amount: $150,000.00
 

Abstract:

This Small Business Technology Transfer Phase I project develops molecular biology, biochemical engineering, and purification techniques to provide small interfering RNA or siRNA molecules on at large-scale and at low cost compared to available techniques. In recent years, siRNA's have been recognized as potent gene-silencing agents via RNA interference (RNAi). Genes for important diseases such as cancer, HIV, and hepatitis have already been shown to be controllable by siRNA action. Applications of siRNA's now warrant large-scale manufacture of siRNAs for the purposes of RNAi associated studies and as pharmaceutical agents. Unique to the technology is our well demonstrated evidence that RNA insert sequences can be harbored in larger ribosomal RNA (rRNA) carriers and produced at high levels within E. coli by conventional fermentation. Following fermentation, the desired siRNA is excised and purified for large-scale production of the RNA product. The broader impacts of this research is to provide a general, large-scale production tool applicable to a wide range of future novel RNA products. In addition to siRNA production, the methods proposed here can be used for large-scale production of micro-RNAs, aptamers, antisense therapeutics, or other short RNA molecules that are also of considerable interest for structural and pharmacological applications. The associated products and RNA expression systems are expected to have considerable commercial value, first in the research community and eventually as pharmaceuticals. This project will also result in fundamental scientific knowledge regarding RNA structure, enzymatic action, and purification of particular RNA molecules.

Principal Investigator:

George W. Jackson
DPhil
7137410111
bill@biotexmedical.com

Business Contact:

George W. Jackson
DPhil
7137410111
bill@biotexmedical.com
Small Business Information at Submission:

BioTex, Inc.
8058 El Rio St. Houston, TX 77054

EIN/Tax ID: 742824041
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
University of Houston
316 E Cullen
Houston, TX 77204 2015
Contact: George Fox
Contact Phone: (713) 743-9104
RI Type: Nonprofit college or university